Please Follow us on Gab, Minds, Telegram, Rumble, Gettr, Truth Social, Twitter
The Department of Health and Human Services (HHS) announced Tuesday the appointment of Harvey Risch, M.D., Ph.D., to head President Donald Trump’s Cancer Panel.
“Dr. Risch brings the expertise and resolve needed to identify the root causes of cancer in America,” said HHS Secretary Robert F. Kennedy, Jr. in a press statement.
“He will push this work forward, confront the factors driving cancer rates, and provide the public with science they can trust,” Kennedy added. “This appointment strengthens our national fight against cancer and reflects our duty to protect Americans’ health with transparency, independence, and rigorous inquiry.”
Risch is Professor Emeritus and Senior Research Scientist in Epidemiology at the Yale School of Public Health and Yale School of Medicine. As the HHS press statement notes, much of his career has been spent studying “cancer etiology, prevention, early diagnosis, and epidemiological methods,” with research in the areas of “ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and cancers related to the use of oral contraceptives and noncontraceptive estrogens.”
An editor of the International Journal of Cancer, Risch also served for 25 years as associate editor of the Journal of the National Cancer Institute, and for six years as a member of the American Journal of Epidemiology’s Board of Editors.
In his new role as chairman of the President’s Cancer Panel, HHS said Risch intends to hasten the United States’ advances in cancer prevention and educate Americans regarding “reproductive, dietary, occupational, environmental, and immune system-related factors that influence cancer etiology.”
“This Panel has access to the best minds, cutting edge science, and vast resources required to radically advance Americans’ understanding of cancer development, diagnosis, and prevention,” Risch said in the statement. “We are sitting on the treasure trove of knowledge necessary to demystify the causes of cancer, and we can use that knowledge to help Americans live fuller, freer lives. Cancer does not have to loom over the American people as an unknowable specter.”
Risch had been heard numerous times during the COVID pandemic era on Connecticut-based WTIC’s The Todd Feinburg Show. In November 2021, Risch explained to listeners that it is “natural immunity,” rather than “vaccine immunity” that will get the United States out of the pandemic.
The Yale epidemiologist discussed the use of traditional drugs to treat the COVID virus as well as their suppression due to conflicts of interest.
“I think the evidence has grown stronger with time that these things are effective in reducing risks of hospitalization and mortality when they’re used within the first five days, say, or six days of symptom onset,” Risch said at the time. “And I think that, you know, as more people understand this, and understand how they’ve been suppressed because of conflicts of interest, you know, people are getting angry about why the governments have been suppressing this, and why, you know, the media have been suppressing this as well. But I’m optimistic that the more people find out, the more people use it.”
During a special report Wednesday with Just the News-Real America’s Voice, Risch said he hopes to conduct more “formal studies” on the use of traditional drugs, such as ivermectin and hydroxychloroquine (HCQ), as potential cancer treatments.
“I’ve had a lot of anecdotal reports telling me that doctors have treated their patients with those medications,” he said, but acknowledged he is cautious until further research is done.
“I don’t want to overpromise, because everybody will get disappointed,” he observed, but also noted that cancer “is a highly treatable disease.”
With an emphasis on prevention, Risch told Just the News the pharmaceutical industry needs to work on “safe and low-cost” cancer prevention medications, which, he said, “they could patent and make money off of” in addition to post-diagnosis treatments.
“It’s a question of … being able to sort the fringe from the real,” he said, stressing the need for “more formal evaluation” of any drugs and supplements purported to treat cancer.
Risch noted during the interview that while quitting smoking remains the best way to prevent cancer, research on identifying dietary factors has improved, including use of some “common oils” in cooking that have been shown to be “inflammatory.”
According to HHS, the President’s Cancer Panel was established in 1971 via the National Cancer Act and is part of the National Institutes of Health’s (NIH) National Cancer Institute.
The panel “is charged with monitoring the development and execution of the activities of the National Cancer Program and reporting to the president on progress, efficacy, and opportunities for improvement in the national effort against cancer,” the department states.
“The field of cancer prevention is only 75 years old,” said NIH Director Dr. Jay Bhattacharya in the HHS press statement. “Great developments in our understanding of this subject should not shock us — they should be expected. Dr. Risch is a distinguished pioneer in the study of cancer epidemiology with the background to help bring the revelations to the field we’re seeking.”
Stay updated with the latest in the Constitution State with The CT Centinal
